NCT06463145View on ClinicalTrials.gov

Study of the Anxiolytic Effects of Aframomum Seed Extract in Elderly People

NACompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

March 1, 2023

Primary Completion Date

April 12, 2023

Study Completion Date

May 20, 2023

Conditions
Situational Anxiety
Interventions
DIETARY_SUPPLEMENT

Vanizem

Aframomum melegueta seed extract standardized to 10% of total Vanilloid and at least 1.5% of 6-paradol

DIETARY_SUPPLEMENT

Placebo

Food grade Maltodextrin 12

Trial Locations (1)

3005

Kinetic perfomance SL, Alicante

Sponsors

Lead Sponsor

Nektium Pharma SL
All Listed Sponsors
collaborator

Kinetic performance

UNKNOWN

lead

Nektium Pharma SL

INDUSTRY

NCT06463145 - Study of the Anxiolytic Effects of Aframomum Seed Extract in Elderly People | Biotech Hunter | Biotech Hunter